πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

719 results for β€œLI” Clear

  1. telisotuzumab

    NMPA: clinical trials

  2. telisotuzumab vedotin-tllv

    EMRELIS

    SINGLE-DOSE FDA: approved

  3. telitacicept

    NMPA: clinical trials

  4. telithromycin

    KETEK

    ORAL FDA: approved Β· EMA: withdrawn

    J01FA15
  5. temsirolimus

    TORISEL

    INTRAVENOUS FDA: approved Β· EMA: approved

    L01XE09
  6. teneligliptin

    NMPA: clinical trials

  7. teneligliptin hydrobromide hydrate

    TENELIA

    PMDA: approved

  8. teplizumab

    TEIZEILD

    EMA: approved Β· NMPA: clinical trials

    A10XX01
  9. teplizumab-mzwv

    TZIELD

    INJECTION FDA: approved

  10. terbutaline

    BRICANYL AstraZeneca

    TGA: approved

  11. terbutaline sulfate

    TERBUTALINE SULFATE

    ORAL FDA: approved

  12. terlipressin

    NMPA: clinical trials

  13. terlipressin acetate

    TERLIVAZ

    INTRAVENOUS FDA: approved

  14. terlipressinum

    NMPA: clinical trials

  15. tesamorelin

    EGRIFTA

    EMA: application withdrawn Β· NMPA: clinical trials

  16. tesamorelin acetate

    EGRIFTA

    SUBCUTANEOUS FDA: approved

  17. tetracycline hydrochloride

    TETRACYN Amneal Pharma Europe Ltd

    TOPICAL FDA: approved

  18. tetracycline phosphate complex

    TETREX

    ORAL FDA: approved

  19. tetrahydrozoline hydrochloride

    TYZINE

    NASAL FDA: approved

  20. thalidomide

    THALOMID Bristol-Myers Squibb Australia Pty Ltd

    ORAL FDA: approved Β· EMA: approved Β· TGA: approved Β· PMDA: approved Β· NMPA: clinical trials

    L04AX02
  21. theophylline

    NUELIN Lacuna Pharma Pty Ltd

    INJECTION FDA: approved Β· TGA: approved

  22. theophylline sodium glycinate

    ASBRON

    ORAL FDA: approved

  23. ticarcillin disodium

    TICAR

    INJECTION FDA: approved

  24. tigecycline

    TIGECYCLINE ACCORD Amneal Pharma Europe Ltd

    INTRAVENOUS FDA: approved Β· EMA: approved Β· NMPA: clinical trials

    J01AA12

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources